Literature DB >> 9201102

Effect of dietary nucleotides on degree of fibrosis and steatosis induced by oral intake of thioacetamide.

M I Torres1, M I Fernandez, A Gil, A Rios.   

Abstract

The administration of thioacetamide in rats induces nodular cirrhosis of the liver, characterized by fibrous septae, parenchymal nodules, proliferation of the bile ducts, and excessive deposition of connective tissue elements. Nodular cirrhosis is also associated with changes in lipid metabolism, as shown by the accumulation of lipid droplets in the hepatocyte cytoplasm. Adequate nutritional support during cirrhosis is important to sustain liver function and promote recovery after the lesions have been induced. Supplementation with nucleotides may increase cellular proliferation and thus optimize hepatic recovery. The aim of this study was to investigate the effects of dietary nucleotide supplementation on the degree of fibrosis and steatosis in rats with liver cirrhosis induced by four months of oral intake of thioacetamide. The use of dietary nucleotides after thioacetamide administration was found to decrease the percentage area of fibrous septae. In animals with liver cirrhosis fed the nucleotide-supplemented diet for two weeks, the total area of fibrosis was reduced. Withdrawal of the hepatotoxic agent led to a decrease in the degree of steatosis in cirrhotic animals, which was significant in rats given the nucleotide-supplemented diet during a two-week recovery period. In conclusion, dietary nucleotides may be an important factor in the histological recovery of damaged liver in experimental cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201102     DOI: 10.1023/a:1018882913983

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Portal hypertension in chronic liver disease.

Authors:  J Schölmerich
Journal:  Hepatogastroenterology       Date:  1991-10

Review 2.  Liver regeneration: an overview.

Authors:  N L Bucher
Journal:  J Gastroenterol Hepatol       Date:  1991 Nov-Dec       Impact factor: 4.029

3.  Effect of nucleotide and nucleoside mixture on rats given total parenteral nutrition after 70% hepatectomy.

Authors:  S Ogoshi; M Iwasa; T Yonezawa; T Tamiya
Journal:  JPEN J Parenter Enteral Nutr       Date:  1985 May-Jun       Impact factor: 4.016

4.  Nucleotides and nutrition: role as dietary supplement.

Authors:  W A Walker
Journal:  J Nutr       Date:  1994-01       Impact factor: 4.798

5.  Dietary long-chain polyunsaturated fatty acids influence the recovery of thioacetamide-induced liver cirrhosis in rats.

Authors:  E Moreira; L Fontana; M I Torres; I Fernández; A Ríos; F Sánchez de Medina; A Gil
Journal:  JPEN J Parenter Enteral Nutr       Date:  1995 Nov-Dec       Impact factor: 4.016

6.  Effect of dietary nucleosides on growth and maturation of the developing gut in the rat.

Authors:  R Uauy; G Stringel; R Thomas; R Quan
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-05       Impact factor: 2.839

7.  De novo purine nucleotide synthesis in the rat small and large intestine: effect of dietary protein and purines.

Authors:  N S LeLeiko; A D Bronstein; B S Baliga; H N Munro
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983-05       Impact factor: 2.839

8.  Effect of dietary nucleotides on small intestinal repair after diarrhoea. Histological and ultrastructural changes.

Authors:  J Bueno; M Torres; A Almendros; R Carmona; M C Nuñez; A Rios; A Gil
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

9.  Effect of dietary nucleotides on the plasma fatty acids in at-term neonates.

Authors:  A Gil; M Pita; A Martinez; J A Molina; F Sánchez Medina
Journal:  Hum Nutr Clin Nutr       Date:  1986-05

10.  Effects of total parenteral nutrition with nucleoside and nucleotide mixture on D-galactosamine-induced liver injury in rats.

Authors:  S Ogoshi; M Iwasa; S Kitagawa; Y Ohmori; S Mizobuchi; Y Iwasa; T Tamiya
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Jan-Feb       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.